18th CANDIAN MELANOMA CONFERENCE 2024: Pfizer Lunch Symposium: Bridging The Evidence Gap For Targeted Therapy Usein BRAF V600 Metastatic Melanoma: Reconciling Clinical Trial Data And RealWorld Evidenc